Intelligene智新生技

08/05/2025

🎉 智新生技，嶄新啟程！興櫃前法人說明會暨興櫃登錄成功！ 🎉
智新生技興櫃前法說會在5/6圓滿落幕並於5/8登錄興櫃，這也是我們全球佈局的第一步!

在5/6的興櫃前法說會，我們向現場150位國內外貴賓分享智新RNA研發技術平台的願景與策略、說明我們當前的研發進度與分享智新在拓展國際合作的成績。我們深深感受到現場每一份熱情與肯定，而這是屬於所有支持智新夥伴們的榮耀時刻！

而今天（5/8），我們要驕傲地宣布，智新生技正式登錄興櫃！這是邁向國際穩健的第一步，而未來的每一步都將因為有各位工作夥伴與股東的支持，會更加堅定有力，讓來自台灣的智新生技的RNA核酸技術與藥物走上國際舞台！

We’re excited to share some incredible milestones at Intelligene!

On May 6, we successfully hosted our pre-listing investor conference, where we welcomed 150 distinguished guests from Taiwan and abroad. We shared our vision and strategy for Intelligene’s RNA platform technology, updated attendees on our R&D progress, and highlighted the strides we’ve made in building international collaborations. The energy and support in the room were truly inspiring — this moment belongs to everyone who has supported Intelligene along the way!

And today, May 8, we’re proud to announce that Intelligene is officially listed on Taiwan’s Emerging Stock Market! This marks a major first step in our global journey. With the continued dedication of our team and the trust of our shareholders, we’re more determined than ever to bring RNA technologies and therapeutics from Taiwan to the international stage.

Thank you to our incredible team, partners, and supporters — we couldn’t have reached this point without you!

媒體報導看這裡
經濟日報 | https://reurl.cc/EVYl5m
環球生技 | https://reurl.cc/dQOkZV
鉅亨網 | https://reurl.cc/qGaAeq

19/02/2025

智新生技與澳洲頂尖研究機構簽署RNA藥物合作開發協議，將獲BRIDGE計劃贊助最高500萬澳幣

智新生技正式與主辦澳洲BRIDGE計劃（核酸新藥研究開發計劃）的國際頂尖研究機構Kirby Institute完成RNA核酸新藥合作開發合約簽署，將獲BRIDGE計劃贊助最高500萬澳幣（約新台幣1億元）之同等研究資源，以加速IG-001新藥的開發。

了解更多詳情：https://www.ctee.com.tw/news/20250219700171-439901

智新生技官網 https://www.intelli-gene.com/news/detail/106

24/01/2025

龍年收工啦！今天是龍年的最後一個工作日，智新生技祝福大家在新的一年金蛇繞福，好運亨通，快樂迎新春！

Wishing everyone a prosperous and joyful Lunar New Year! As we enter the Year of the Snake, may good fortune snake its way into your life, bringing health, success, and innovation!

01/01/2025

24/12/2024

As 2024 comes to a close, we at are filled with gratitude for the incredible progress we've made in the world of RNA-based therapeutics. This year has been one of growth, discovery, and collaboration, and we couldn't be more excited for what lies ahead.

To all our partners, supporters, and team members—thank you for being part of this amazing journey.

Wishing you a Merry Christmas and a Happy New Year filled with health, happiness, and hope. Here's to advancing science, transforming healthcare, and making a positive impact in the world in 2025!

09/12/2024

https://news.gbimonthly.com/tw/magazine/article_show.php?num=73117&range=news

感謝環球生技月刊 Global Bio & Investment分享了我們的故事。

智新生技致力於推動針對COVID-19和流感的RNA創新療法。在BARDA的支持以及澳洲BRIDGE計劃技術以及資金的加持下，我們將持續努力推進RNA新藥開發，為人類健康作出貢獻！

We’re honored to have our journey highlighted by Global Bio & Investment Monthly.

Founded in 2023, hashtag is driving innovation in RNA -based therapies for COVID-19 and influenza. With support from BARDA and funding from Australia’s BRIDGE program, we remain dedicated to advancing RNA therapeutics to improve human health.

21/11/2024

We’re currently seeking for a skilled Procurement professional to join our team! If you are proactive, results-driven, detailed-oriented and have a passion for optimizing procurement process, we’d love to hear from you!

【職位名稱】採購專員

【工作內容】
1. 依各類採購需求，詢比議價及採購相關作業
2. 負責鼎新ERP系統請款相關作業(收貨單、發票核對與收貨請款時程追蹤)
3. 新供應商開發，供應商建檔管理
4. 協助處理研發部門行政相關事務
5. 主管交辦事項
6. 熟悉電腦Excel與ERP系統操作經驗者佳

【人才需求】
1. 生技藥廠經驗者尤佳
2. 鼎新ERP使用經驗者佳
3. 二年以上採購經驗佳
4. 細心、負責、肯學習、具服務熱忱
5. 生化、藥學相關背景佳
6. 優異的溝通能力：良好的溝通與組織能力，能夠與供應商和內部團隊有效溝通，達成合作目標
7. 抗壓性強：面對新創產業快速步調，能迅速反應並即時調整
8. 解決問題能力：能夠迅速解決業務執行過程中的問題和挑戰，提出解決方案
9. 團隊合作：能夠有效地與內部與外部部門合作，協調各方面的需求

台北市南港區 - 採購與行政事務工作內容 1. 依各類採購需求，詢比議價及採購相關作業 2. 負責鼎新ER...。薪資：待遇面議（經常性薪資達4萬元或以上）。職務類別：採購助理、採購人員。找工作請上104人力銀行。

06/11/2024

歡迎加入智新生技！我們正在找 人資/行政 人才，如果有朋友對生技新創產業有興趣又喜歡充滿活力的企業文化，歡迎申請或是推薦人才喔！

We’re on the lookout for a passionate HR/Admin Associate to join our journey of innovation in biotech!

This is an unique opportunity to grow with us and be part of an exciting, purpose-driven environment. If you’re dedicated, motivated, and ready to make an impact, we’d love to hear from you!

台北市南港區 - 1. 與高階主管合作，共同制定並推動人力資源策略，以促進公司策略發展和團隊文化建立。 2. 負責推動...。薪資：待遇面議（經常性薪資達4萬元或以上）。職務類別：人力資源人員、行政人員。找工作請上104人....

25/10/2024

We’re thrilled to share that Jerry Huang, 's Chairman & CEO has been recognized as one of the Top 10 CEOs in Biotech in Taiwan by 環球生技月刊! This honor reflects our commitment to advancing drug development and our vision for the future of healthcare.

At Intelligene, we are proud to be at the forefront of innovation in the industry, particularly in our efforts to develop RNA therapies for infectious diseases. Participating in the CEO Award competition gave us a great opportunity to showcase our groundbreaking work and share our journey with everyone.

We are dedicated to pushing the boundaries of science and technology to improve patient outcomes and enhance public health. Thank you for your continued support as we work to make a difference in the world.

13/09/2024

#智新生技 正式進駐 #台北生技園區 囉！特別感謝昨天來參加喬遷Party的貴賓們，有你們的支持，智新生技將更加努力成長茁壯！
在智新生技，我們致力於為我們的員工打造一個創新又充滿活力的工作環境，歡迎對生技產業有興趣的人才加入我們的團隊，讓我們一起推動革新型基因療法的發展！

We are beyond excited to announce our successful move to the new office at Taipei Biotech Park (台北生技園區)! A huge thank you to all our esteemed guests and investors who joined us at our move-in party yesterday—you truly made the event unforgettable!

At , we’re committed to creating an , , and welcoming environment where innovation thrives. Our new space is a reflection of that dedication, supporting the well-being and productivity of our talented team as we push the boundaries of biotech advancements.

This marks a thrilling milestone in our journey, and we’re so grateful to have you with us!

29/07/2024

We are thrilled to share highlights from BioAsia Taiwan, where our Chief Financial & Sustainability Officer, Sean Huang, delivered an inspiring session on our groundbreaking RNA technology.

“We aim to redefine the boundaries of medicine and to improve global health by harnessing the revolutionary power of our technology platform.” – Sean Huang, CFO&CSO,

"我們專注於運用革命性創新的核酸技術平台，突破傳統藥物研發的侷限，進而改善全球醫療與健護發展。" ~Sean Huang/ #智新生技 財務長暨永續經營長

Thank you to everyone who joined us to explore the future of medicine!

22/07/2024

🎉 Join us at the Taipei NangGang Exhibition Center for exciting events in BioAsia Taiwan! 🎉

🗓️ July 24: Don't miss our President and COO, Patty Sung, at the AUSTRALIA-TAIWAN CLINICAL TRIALS AND BIOTECH FORUM! She'll be a panelist discussing "Exploring Next-Generation Therapies through Innovative Solutions".
11:40- 12:15 台澳創新療法的發展與契機
與談講者：宋佩怡/智新生技總經理
(台北南港展覽館二館7樓703室)

🗓️ July 25: Our Chief Financial & Sustainability Officer, Sean Huang, will dive into the "Exploring Unlimited Possibilities of RNAi Therapeutics" in his speaker session.
11:35-11:55 開創生技新藍海- 掌握RNAi核酸藥物新契機
主講：黃式賢/ 智新生技財務長暨永續發展長
(南港展覽館1館4樓N區M436 臺北生技館)

📍 Location: Taipei NangGang Exhibition Center

Get ready to explore the future of biotech with us! 🚀✨